| 1 |
31423579 | JAK1/2 pathway inhibition suppresses M2 polarization and overcomes resistance of myeloma to lenalidomide by reducing TRIB1, MUC1, CD44, CXCL12, and CXCR4 expression. | 2020 Jan |
1 |
| 2 |
28643330 | MUC1-C is a target in lenalidomide resistant multiple myeloma. | 2017 Sep |
1 |
| 3 |
26429859 | HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide. | 2015 Oct 13 |
2 |
| 4 |
23760401 | Evidence of a role for CD44 and cell adhesion in mediating resistance to lenalidomide in multiple myeloma: therapeutic implications. | 2014 Feb |
6 |